- Home
- SAP vs JNJ Comparison
SAP vs JNJ Comparison
Compare SAP & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAP
- JNJ
- Stock Information
- Founded
- SAP 1972
- JNJ 1886
- Country
- SAP Germany
- JNJ United States
- Employees
- SAP N/A
- JNJ 139800
- Industry
- SAP Computer Software: Prepackaged Software
- JNJ Biotechnology: Pharmaceutical Preparations
- Sector
- SAP Technology
- JNJ Health Care
- Exchange
- SAP Nasdaq
- JNJ Nasdaq
- Market Cap
- SAP 353.3B
- JNJ 406.9B
- IPO Year
- SAP 1998
- JNJ 1944
- Fundamental
- Price
- SAP $286.86
- JNJ $168.04
- Analyst Decision
- SAP Buy
- JNJ Buy
- Analyst Count
- SAP 6
- JNJ 15
- Target Price
- SAP $314.60
- JNJ $173.00
- AVG Volume (30 Days)
- SAP 1.4M
- JNJ 8.7M
- Earning Date
- SAP 07-22-2025
- JNJ 07-16-2025
- Dividend Yield
- SAP 0.67%
- JNJ 3.07%
- EPS Growth
- SAP 156.14
- JNJ N/A
- EPS
- SAP 6.52
- JNJ 9.33
- Revenue
- SAP $42,145,625,368.00
- JNJ $90,627,000,000.00
- Revenue This Year
- SAP $11.19
- JNJ $3.99
- Revenue Next Year
- SAP $11.77
- JNJ $4.17
- P/E Ratio
- SAP $43.87
- JNJ $18.17
- Revenue Growth
- SAP 10.28
- JNJ 4.68
- 52 Week Low
- SAP $194.93
- JNJ $140.68
- 52 Week High
- SAP $313.28
- JNJ $169.99
- Technical
- Relative Strength Index (RSI)
- SAP 36.28
- JNJ 73.19
- Support Level
- SAP $296.90
- JNJ $162.78
- Resistance Level
- SAP $309.73
- JNJ $169.99
- Average True Range (ATR)
- SAP 4.14
- JNJ 2.48
- MACD
- SAP -2.37
- JNJ 1.20
- Stochastic Oscillator
- SAP 3.43
- JNJ 93.28
About SAP SAP SE ADS
Founded in Germany in 1972 by former IBM employees, SAP is the world's largest provider of enterprise application software. Known as the leader in enterprise resource planning software, SAP's portfolio also includes software for supply chain management, procurement, travel and expense management, and customer relationship management, among others. The company operates in more than 180 countries and has more than 400,000 customers, approximately 80% of which are small to medium-size enterprises.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.